CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PIERCE, J. A
Right arrow Articles by GAROFALO, M. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by PIERCE, J. A
Right arrow Articles by GAROFALO, M. L.

Canadian Journal of Anesthesia, Vol 12, 179-191, Copyright © 1965 by Canadian Anesthesiologists' Society

Anaesthetic Management for Cardiopulmonary Bypass A Review of 200 Cases

JOHN A PIERCE MD1 and MARIO L. GAROFALO MD1

1 Department of Anesthesiology, Hospital of Saint Raphael, New Haven, Connecticut

Two hundred, unselected, consecutive open-heart operations using cardiopulmonary bypass are reviewed with particular reference to methods and results. An attempt was made to correlate primary anaesthetic agents used and in-hospital mortality. Nitrous oxide was never implicated in any of the deaths where it was used as the primary anaesthetic agent. In those cases where halogenated agents were used, methoxyflurane had the highest in-hospital mortality rate, halothane was next, and fluroxene had the least number of deaths where anaesthesia could be implicated. On the basis of our results and interpretations, fluroxene would appear to be the anesthetic agent of choice in managing patients for open-heart surgery using cardiopulmonary bypass.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the Canadian Anesthesiologists' Society.